Affiliation:
1. Institute of Biochemistry and Clinical Biochemistry, School of Medicine, Catholic University, Rome, Italy
2. Department of Laboratory Medicine, Madre Giuseppina Vannini Hospital, Rome, Italy
Abstract
Background:
Mitochondria are remarkably gaining significant and different
pathogenic roles in cancer (i.e., to sustain specific metabolism, to activate signaling pathways,
to promote apoptosis resistance, to favor cancer cell dissemination, and finally to facilitate
genome instability). Interestingly, all these roles seem to be linked to the fundamental activity
of mitochondria, i.e. oxidative metabolism. Intriguingly, a typical modification of mitochondrial
oxidative metabolism and reactive oxygen species production/ neutralization seems to
have a central role in all these tangled pathogenic roles in cancer. On these bases, a careful
understanding of the molecular relationships between cancer and mitochondria may represent
a fundamental step to realize therapeutic approaches blocking the typical cancer progression.
The main aim of this review is to stress some neglected aspects of oxidative mitochondrial
metabolism of cancer cells to promote more translational research with diagnostic and therapeutic
potential.
Methods:
We reviewed the available literature regarding clinical and experimental studies on
various roles of mitochondria in cancer, with attention to the cancer cell mitochondrial metabolism.
Results:
Mitochondria are an important source of reactive oxygen species. Their toxic effects
seem to increase in cancer cells. However, it is not clear if damage depends on ROS overproduction
and/or defect in detoxification. Failure of both these processes is likely a critical
component of the cancer process and is strictly related to the actual microenvironment of cancer
cells.
Conclusions:
Mitochondria, also by ROS production, have a fundamental
pathogenetic role in promoting and maintaining cancer and its spreading. To
carefully understand the tangled redox state of cancer cells mitochondria represents
a fundamental step to realize therapeutic approaches blocking the typical cancer
progression.
Funder
European Cooperation in Science and Technology
Catholic University
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献